GASTRIC CANCER ADENOCARCINOMA METASTATIC
Clinical trials for GASTRIC CANCER ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for GASTRIC CANCER ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outsmart Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests an experimental drug called OKN4395, taken as a pill, alone or together with the immunotherapy pembrolizumab. The goal is to find a safe dose and see if the combination can shrink tumors in people with advanced solid cancers like lung, colorectal, sto…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: Epkin • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for stomach cancer patients when immunotherapy fails
Disease control Recruiting nowThis study tests a new combination of drugs for people with advanced stomach cancer that got worse after initial immunotherapy. The treatment includes a targeted therapy (fruquintinib), chemotherapy (nab-paclitaxel), and a new immunotherapy (iparomlimab and tuvonralimab). The goa…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Dai, Guanghai • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug BDC-4182 targets stomach cancer by waking up the immune system
Disease control Recruiting nowThis early-phase trial is testing a new drug called BDC-4182 in people with advanced gastric or gastroesophageal cancer that has spread or cannot be removed. The drug is designed to attach to a protein on cancer cells and stimulate the immune system to attack them. The study will…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo targets stomach cancer protein in 100-Patient trial
Disease control Recruiting nowThis study tests whether adding the targeted drug zolbetuximab to standard chemotherapy (paclitaxel and ramucirumab) can help people with advanced stomach or gastroesophageal cancer live longer. It includes 100 adults whose tumors have a specific protein called CLDN18.2. Particip…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Triple-Drug cocktail targets stomach cancer that has spread to the abdomen
Disease control Recruiting nowThis study tests a combination of three drugs—lenvatinib, nivolumab, and chemotherapy—in people with advanced stomach cancer that has spread to the lining of the abdomen and caused fluid buildup (ascites). The goal is to see if this triple therapy can shrink tumors and help patie…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC